Steve Ryder (S Ryder)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 5

Top Topics

Prostate Cancer

Systematic Review

Duchenne Muscular Dystrophy

Tyrosine Kinase

Top Venues

Future oncology (London, England)

Orphanet journal of rare diseases

PharmacoEconomics

Clinical epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Nigel Armstrong, Nasuh C Buyukkaramikli, Hannah Penton, Rob Riemsma, Pim Wetzelaer, Vanesa Huertas Carrera, Stephanie Louise Swift, Thea Marie Drachen, Heike Raatz, Steve Ryder, Dhwani Shah, Titas Buksnys, Gill Worthy, Steven Duffy, Maiwenn Al, Jos M P Kleijnen
Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis. Health technology assessment (Winchester, England) 24 (51) (2021)
Nigel Armstrong, Ruben G W Quek, Steve Ryder, Janine Ross, Titas Buksnys, Carol Forbes, Kathleen M Fox, Elena Castro
DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review. Future oncology (London, England) 17 (7) (2020)
Steve Ryder, Kathleen Fox, Pratik Rane, Nigel Armstrong, Ching-Yun Wei, Sohan Deshpande, Lisa Stirk, Yi Qian, Jos Kleijnen
A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective. PharmacoEconomics 37 (7) (2020)
Nigel Armstrong, Steve Ryder, Carol Forbes, Janine Ross, Ruben G W Quek
A systematic review of the international prevalence of BRCA mutation in breast cancer. Clinical epidemiology 11 (2019)
Steve Ryder, R M Leadley, N Armstrong, M Westwood, S de Kock, T Butt, M Jain, J Kleijnen
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet journal of rare diseases 12 (1) (2017)